Quent Capital’s Novartis NVS Stock Holding History

Quent Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.27K	Hold	44	–	–	﹤0.01%	1358
2026 Q2	$6.9K	Buy	44 +8	+22%	+$1.2K	﹤0.01%	1315
2026 Q1	$5.5K	Hold	36	–	–	﹤0.01%	1260
2025 Q4	$4.96K	Hold	36	–	–	﹤0.01%	1276
2025 Q3	$4.62K	Buy	+36	New	+$4.39K	﹤0.01%	1161
2025 Q2	–	Sell	-36	Closed	-$4.01K	–	931
2025 Q1	$4.01K	Sell	36 -90	-71%	-$9.6K	﹤0.01%	1051
2024 Q4	$12.3K	Hold	126	–	–	﹤0.01%	895
2024 Q3	$14.5K	Hold	126	–	–	﹤0.01%	945
2024 Q2	$13.4K	Hold	126	–	–	﹤0.01%	939
2024 Q1	$12.2K	Hold	126	–	–	﹤0.01%	979
2023 Q4	$12.7K	Hold	126	–	–	﹤0.01%	929
2023 Q3	$12.8K	Hold	126	–	–	﹤0.01%	882
2023 Q2	$12.7K	Hold	126	–	–	﹤0.01%	887
2023 Q1	$11.6K	Sell	126 -5	-4%	-$437	﹤0.01%	895
2022 Q4	$11.9K	Hold	131	–	–	﹤0.01%	864
2022 Q3	$10K	Buy	131 +50	+62%	+$4.14K	﹤0.01%	864
2022 Q2	$7K	Sell	81 -480	-86%	-$42.1K	﹤0.01%	898
2022 Q1	$49K	Hold	561	–	–	0.01%	600
2021 Q4	$49K	Buy	+561	New	+$46.6K	0.01%	549

Other funds holding NVS

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $94.1B AUM 31.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $273B AUM 15.34% 1-Year Est. Return

Quent Capital's NVS Position: Q3 2026 in Review

Quent Capital held its Novartis (NVS) position steady in Q3 2026 at 44 shares worth $6.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1358.

Quent Capital first reported a position in NVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $49K in Q1 2022. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

Quent Capital held 44 shares of Novartis worth $6.27K as of Q3 2026.
Quent Capital left its Novartis share count unchanged in Q3 2026.
Novartis made up ﹤0.01% of Quent Capital's portfolio in Q3 2026, its #1358 holding.
Quent Capital first reported a position in Novartis in Q4 2021 and has held it in 19 quarters since.
Quent Capital's Novartis position peaked at $49K in Q1 2022.
1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.